• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?

作者信息

Zuin Marco, Cervellati Carlo, Rigatelli Gianluca, Zuliani Giovanni, Roncon Loris

机构信息

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

出版信息

Thromb Res. 2021 Dec;208:170-172. doi: 10.1016/j.thromres.2021.11.008. Epub 2021 Nov 16.

DOI:10.1016/j.thromres.2021.11.008
PMID:34801920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8594077/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c48/8594077/a09bd88211eb/mmc3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c48/8594077/66c9fd54c2f1/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c48/8594077/911fbaab548a/mmc2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c48/8594077/a09bd88211eb/mmc3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c48/8594077/66c9fd54c2f1/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c48/8594077/911fbaab548a/mmc2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c48/8594077/a09bd88211eb/mmc3_lrg.jpg

相似文献

1
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?降低COVID-19患者静脉血栓栓塞事件：白细胞介素-6拮抗剂起何种作用？
Thromb Res. 2021 Dec;208:170-172. doi: 10.1016/j.thromres.2021.11.008. Epub 2021 Nov 16.
2
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.COVID-19中的静脉血栓栓塞性疾病：病理生理学、治疗与预防
Int J Mol Sci. 2022 Sep 8;23(18):10372. doi: 10.3390/ijms231810372.
3
Risk stratification for SARS-CoV-2-related venous thromboembolic events: time for a new paradigm?2019冠状病毒病相关静脉血栓栓塞事件的风险分层：是时候采用新范式了吗？
Anaesthesia. 2022 Jan;77(1):3-6. doi: 10.1111/anae.15610. Epub 2021 Nov 5.
4
Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19.新型冠状病毒肺炎（COVID-19）感染患者中与静脉血栓栓塞事件相关的转氨酶紊乱
Ann Hepatol. 2021 Jul-Aug;23:100306. doi: 10.1016/j.aohep.2021.100306. Epub 2021 Jan 9.
5
Reply to :Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19.回复：新型冠状病毒肺炎患者中与静脉血栓栓塞事件相关的转氨酶紊乱
Ann Hepatol. 2021 Jul-Aug;23:100334. doi: 10.1016/j.aohep.2021.100334. Epub 2021 Feb 20.
6
Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications.在 COVID-19 中报告静脉血栓栓塞表型的异质性：方法学问题和临床意义。
Br J Haematol. 2020 Aug;190(4):529-532. doi: 10.1111/bjh.16993. Epub 2020 Jul 26.
7
Ischemic Priapism in a 12 Year Old Patient Associated With Coronavirus Disease 2019 (COVID-19): A Case Report.12 岁 COVID-19 患者并发缺血性阴茎异常勃起：病例报告
Urology. 2022 Jul;165:316-318. doi: 10.1016/j.urology.2022.01.022. Epub 2022 Jan 23.
8
Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.住院的新冠肺炎患者与静脉血栓栓塞：一场完美风暴。
Circulation. 2020 Jul 14;142(2):129-132. doi: 10.1161/CIRCULATIONAHA.120.048020. Epub 2020 Jul 13.
9
COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort.与流感相比，COVID-19 与静脉血栓形成的风险增加相关，而与动脉血栓形成无关：来自美国大型队列的研究结果。
PLoS One. 2022 Jan 12;17(1):e0261786. doi: 10.1371/journal.pone.0261786. eCollection 2022.
10
Prevalence of proximal deep vein thrombosis in hospitalized COVID-19 patients.住院COVID-19患者近端深静脉血栓形成的患病率。
Eur J Intern Med. 2021 Jul;89:118-120. doi: 10.1016/j.ejim.2021.03.034. Epub 2021 Apr 8.

引用本文的文献

1
Symptomatic Venous Thromboembolic Events in COVID-19 Patients after Hospital Discharge: Aspects to Consider.新冠病毒感染患者出院后有症状的静脉血栓栓塞事件：需考虑的方面
Rev Cardiovasc Med. 2022 Jun 20;23(6):219. doi: 10.31083/j.rcm2306219. eCollection 2022 Jun.
2
Anti-Viral Surfaces in the Fight against the Spread of Coronaviruses.对抗冠状病毒传播的抗病毒表面
Membranes (Basel). 2023 Apr 27;13(5):464. doi: 10.3390/membranes13050464.

本文引用的文献

1
Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.COVID-19 住院患者静脉血栓栓塞症抗凝治疗趋势。
JAMA Netw Open. 2021 Jun 1;4(6):e2111788. doi: 10.1001/jamanetworkopen.2021.11788.
2
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial.托珠单抗联合标准治疗与标准治疗用于印度中重度 COVID-19 相关细胞因子释放综合征（COVINTOC）患者：一项开放标签、多中心、随机、对照、3 期临床试验。
Lancet Respir Med. 2021 May;9(5):511-521. doi: 10.1016/S2213-2600(21)00081-3. Epub 2021 Mar 4.
3
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
COVID-19 重症患者的白细胞介素 6 受体拮抗剂。
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
4
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial.托珠单抗对重症或危重症 2019 冠状病毒病患者 15 天临床结局的影响：随机对照试验。
BMJ. 2021 Jan 20;372:n84. doi: 10.1136/bmj.n84.
5
The Role of Interleukin-6 in the Pathogenesis, Prognosis and Treatment of Severe COVID-19.白细胞介素-6 在严重 COVID-19 发病机制、预后和治疗中的作用。
Curr Med Chem. 2021;28(26):5328-5338. doi: 10.2174/0929867328666201209100259.
6
D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.COVID-19疑似静脉血栓栓塞患者的D-二聚体、纤维蛋白原和白细胞介素-6：一项叙述性综述
Vasc Health Risk Manag. 2020 Nov 13;16:455-462. doi: 10.2147/VHRM.S280962. eCollection 2020.
7
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.托珠单抗治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Dec 10;383(24):2333-2344. doi: 10.1056/NEJMoa2028836. Epub 2020 Oct 21.
8
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.托珠单抗对比常规治疗用于 COVID-19 成人患者伴中重度肺炎的随机临床试验
JAMA Intern Med. 2021 Jan 1;181(1):32-40. doi: 10.1001/jamainternmed.2020.6820.
9
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
10
RoB 2: a revised tool for assessing risk of bias in randomised trials.《随机对照试验偏倚风险评估工具2：修订版》
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.